Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reproducibility of CT-Based Hepatocellular Carcinoma Radiomic Features across Different Contrast Imaging Phases: A Proof of Concept on SORAMIC Trial Data.
Ibrahim A, Widaatalla Y, Refaee T, Primakov S, Miclea RL, Öcal O, Fabritius MP, Ingrisch M, Ricke J, Hustinx R, Mottaghy FM, Woodruff HC, Seidensticker M, Lambin P. Ibrahim A, et al. Among authors: mottaghy fm. Cancers (Basel). 2021 Sep 16;13(18):4638. doi: 10.3390/cancers13184638. Cancers (Basel). 2021. PMID: 34572870 Free PMC article.
Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters.
Zegers CM, van Elmpt W, Wierts R, Reymen B, Sharifi H, Öllers MC, Hoebers F, Troost EG, Wanders R, van Baardwijk A, Brans B, Eriksson J, Windhorst B, Mottaghy FM, De Ruysscher D, Lambin P. Zegers CM, et al. Among authors: mottaghy fm. Radiother Oncol. 2013 Oct;109(1):58-64. doi: 10.1016/j.radonc.2013.08.031. Epub 2013 Sep 14. Radiother Oncol. 2013. PMID: 24044790 Free article.
In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.
Zegers CM, van Elmpt W, Reymen B, Even AJ, Troost EG, Ollers MC, Hoebers FJ, Houben RM, Eriksson J, Windhorst AD, Mottaghy FM, De Ruysscher D, Lambin P. Zegers CM, et al. Among authors: mottaghy fm. Clin Cancer Res. 2014 Dec 15;20(24):6389-97. doi: 10.1158/1078-0432.CCR-14-1524. Epub 2014 Oct 14. Clin Cancer Res. 2014. PMID: 25316821 Free PMC article.
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
van Elmpt W, Zegers CML, Reymen B, Even AJG, Dingemans AC, Oellers M, Wildberger JE, Mottaghy FM, Das M, Troost EGC, Lambin P. van Elmpt W, et al. Among authors: mottaghy fm. Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):240-248. doi: 10.1007/s00259-015-3169-4. Epub 2015 Sep 4. Eur J Nucl Med Mol Imaging. 2016. PMID: 26338178 Free PMC article. Clinical Trial.
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer.
Zegers CM, Hoebers FJ, van Elmpt W, Bons JA, Öllers MC, Troost EG, Eekers D, Balmaekers L, Arts-Pechtold M, Mottaghy FM, Lambin P. Zegers CM, et al. Among authors: mottaghy fm. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2139-2146. doi: 10.1007/s00259-016-3429-y. Epub 2016 Jun 1. Eur J Nucl Med Mol Imaging. 2016. PMID: 27251643 Free PMC article. Clinical Trial.
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach.
Even AJ, Hamming-Vrieze O, van Elmpt W, Winnepenninckx VJ, Heukelom J, Tesselaar ME, Vogel WV, Hoeben A, Zegers CM, Vugts DJ, van Dongen GA, Bartelink H, Mottaghy FM, Hoebers F, Lambin P. Even AJ, et al. Among authors: mottaghy fm. Oncotarget. 2017 Jan 17;8(3):3870-3880. doi: 10.18632/oncotarget.13910. Oncotarget. 2017. PMID: 27965472 Free PMC article.
458 results